Clinical Trials Logo

Uterine Prolapse clinical trials

View clinical trials related to Uterine Prolapse.

Filter by:

NCT ID: NCT03875989 Recruiting - Prolapse, Vaginal Clinical Trials

Vaginal Native Tissues Repair for Pelvic Organ Prolapse

TAPP
Start date: September 27, 2019
Phase: N/A
Study type: Interventional

The aim of the study is to assess at one year the effectiveness of the vaginal patch plastron in comparison of the anterior colporraphy through a combined definition of success: anatomic and functional.

NCT ID: NCT03858673 Completed - Clinical trials for Vault Prolapse, Vaginal

Comparison of PHVP of Different VTH Methods

Start date: January 1, 1986
Phase:
Study type: Observational

To evaluate the post-hysterectomy vault prolapse (PHVP) rates performed using different methods of vaginal total hysterectomy (VTH).

NCT ID: NCT03832543 Completed - Clinical trials for Vault Prolapse, Vaginal

Modified Uterosacral Ligament Suspension in Vaginal Hysterectomy

Start date: April 1, 2016
Phase:
Study type: Observational

Introduction : The extraperitoneal uterosacral ligament suspension (ULS) can be performed during the removal of the uterus in vaginal hysterectomy to prevent cuff prolapse. In this study, the modified extraperitoneal ULS technique was evaluated in terms of preventing cuff prolapse. Methods / Technique : Forty patients with second and third-stage uterine prolapse who were operated were included in the study. During routine vaginal hysterectomy procedure performed on patients, after sacrouterine ligaments which are the first-bites and uteroovarian and round ligaments which are the last-bites have been sutured and knotted, these ligaments were marked with 4-distinct clemps to make the right and left, upper and lower separation. After vaginal cuff was closed the sutures hanged by the clamps were ligated together, and the cuff tissue was stretched to the apical line.

NCT ID: NCT03714607 Active, not recruiting - Cystocele Clinical Trials

Laser Therapy in Managing Vaginal Prolapse

Start date: November 30, 2018
Phase: N/A
Study type: Interventional

Efficacy of laser therapy in postmenopausal women with symptomatic prolapse stage >1. Assessment tools will include prolapse stage quantification system (POP-Q) and validated condition related questionnaires.

NCT ID: NCT03664986 Recruiting - Vaginal Prolapse Clinical Trials

Pudendal Block Using Liposomal Bupivacaine vs. Standard Treatment During Sacrospinous Ligament Fixation

Start date: September 24, 2018
Phase: Phase 4
Study type: Interventional

A pudendal nerve block is a procedure where a local anesthetic is injected where the pudendal nerve is located. This allows quick pain relief to the perineum, vulva, and vagina. The purpose of this research study is see if injecting a long-acting local anesthetic, called Liposomal Bupivacaine (EXPAREL), will result in less post-operative pain after having vaginal prolapse surgery. Typical post-operative pain lasts a few days. Short-acting anesthetics only provide pain relief in the few hours after surgery. EXPAREL will add the benefit of longer acting pain relief that can last up to 72 hours with the same safety profile. EXPAREL is an FDA-approved medication. It has been used and studied extensively in gynecologic surgery for incisional pain. It has also been studied in Urology and Orthopedic surgery with an excellent safety profile with good pain relief.

NCT ID: NCT03658395 Active, not recruiting - Vaginal Prolapse Clinical Trials

Sacrocolpopexy With Posterior Repair Obstructed Defecation Symptoms

Start date: July 19, 2018
Phase: N/A
Study type: Interventional

Participants who undergo laparoscopic sacrocolpopexy (LSCP) plus posterior repair (PR) will demonstrate greater improvement bowel symptom scores compared to participants who undergo LSCP alone at 3 months postoperatively.

NCT ID: NCT03609229 Completed - Prolapse Clinical Trials

Outcomes After Sacrocolpopexy With and Without Burch to Prevent Stress Urinary Incontinence in 3rd and 4th Degree Apical Uterine Prolapse

Start date: September 1, 2018
Phase: N/A
Study type: Interventional

Urinary incontinence will develop after prolapse repair in approximately one quarter of patients with advanced pelvic organ prolapse who remain continent despite significant loss of anterior vaginal and pelvic organ support. Many women with advanced pelvic organ prolapse who choose to undergo surgical management also choose to undergo continence surgery in order to prevent new onset urinary incontinence.

NCT ID: NCT03527082 Not yet recruiting - Prolapse, Vaginal Clinical Trials

Women's Knowledge and Attitudes to Use of Mesh in Gynaecological Surgery

Start date: July 2018
Phase:
Study type: Observational

This is a questionnaire study that is being performed to ascertain the knowledge and attitudes of women towards use of mesh in gynaecological surgery. Women over the age of 18, able to read and comprehend the information leaflet, sign and give informed consent will be eligible to participate. Women who are not fluent in English will be able to participate if a translator can convey the information. The trial will be conducted at Epsom and St Helier Hospitals, in the United Kingdom. The investigators aim to recruit 150 women to this study. No power calculation has been performed as this is an exploratory study. However, previous studies have included 64 and 77 women respectively.

NCT ID: NCT03494582 Completed - Uterine Prolapse Clinical Trials

Abdominal Versus Vaginal Hysteropexy

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

This study will compare the vaginal versus the abdominal approach for the management of uterine prolapse

NCT ID: NCT03436979 Active, not recruiting - Clinical trials for Uterine Prolapse Without Vaginal Wall Prolapse

The NeuGuide™ System for Vaginal Colpopexy in the Treatment of Uterine Prolapse

Start date: January 1, 2018
Phase:
Study type: Observational

The objective of the study is to assess the long term safety, durability of clinical effectiveness and cost effectiveness of the NeuGuide™ system when used for vaginal colpopexy in the treatment of uterine prolapse.